Tocilizumab for Treatment of Severe COVID-19 Patients: Preliminary Results from SMAtteo COvid19 REgistry (SMACORE)

Objective: This study aimed to assess the role of Tocilizumab therapy (TCZ) in terms of ICU admission and mortality rate of critically ill patients with severe COVID-19 pneumonia. Design: Patients with COVID-19 pneumonia were prospectively enrolled in SMAtteo COvid19 REgistry (SMACORE). A retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Colaneri, Marta, Bogliolo, Laura, Valsecchi, Pietro, Sacchi, Paolo, Zuccaro, Valentina, Brandolino, Fabio, Montecucco, Carlomaurizio, Mojoli, Francesco, Giusti, Emanuele Maria, Bruno, Raffaele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285503/
https://www.ncbi.nlm.nih.gov/pubmed/32397399
http://dx.doi.org/10.3390/microorganisms8050695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285503/
https://www.ncbi.nlm.nih.gov/pubmed/32397399
http://dx.doi.org/10.3390/microorganisms8050695

Ejemplares similares